Denmark
3.9researchedA large, sophisticated, fully cash-pay DTC market, and the one Nordic market with a genuinely domestic category leader rather than a pan-European one. You can never own the pharmacy end, because Denmark kept its pharmacist-only concession system under apotekerloven §15, and that turns out to be the moat: Aposund now runs in-person weighing at more than 170 physical pharmacy counters in partnership with Danmarks Apotekerforening, at 140 DKK per four weeks, a price no pure-digital entrant can match. Marketing is the hardest problem here, because Denmark bans video marketing of health services off your own site regardless of whether the drug is named.
- Population
- 6m
- Currency
- DKK
- Region
- Nordic Europe
- Updated
- 2026-08-23
The six axes
Five is always better for an operator. Hover a label for the question it answers.
How it works here
Ownership [1]
Apotekerloven, administered by Lægemiddelstyrelsen: "Et apotek drives af en privatperson – apotekeren – der har fået bevilling fra Lægemiddelstyrelsen til at drive apotek et bestemt sted." The licence is a personal grant tied to a qualified pharmacist. A 2024 consultation response from Danmarks Apotekerforening indicates incremental reform is under discussion, but no deregulation has been enacted.
A foreign founder cannot acquire or control a Danish apotek. Full stop.
The model that actually runs here [1][2]
Every Danish operator uses the same shape: a telehealth clinic staffed by Danish-authorised physicians prescribes via e-recept, and an existing independent apotek dispenses and mails. No pharmacy ownership is involved.
Sikkert Vægttab runs a fixed physician team, video consultations, four-weekly follow-up and a money-back guarantee if there is no weight loss in three months, charging 299 DKK per four weeks in consultation fees plus 855–4,500 DKK/month for the drug. Embla prices Wegovy at 1,283–2,295 DKK/month by dose plus a 995 DKK monthly membership.
Reimbursement and the advertising climate [1][2][3]
On 10 July 2025 Lægemiddelstyrelsen and Medicintilskudsnævnet again refused general conditional tilskud for Wegovy, even for the narrow adolescent severe-obesity subgroup, citing a daily cost of 82.02 DKK, no dedicated trial data for that group, and more than 60% weight regain within 48 weeks of stopping.
On the marketing side, Novo Nordisk's national menopause-targeted "talk to your doctor about weight-loss treatment" campaign drew criticism from Dansk Selskab for Almen Medicin and the medical association; Lægemiddelstyrelsen initially found it lawful, but Novo paused the campaign on 7 November 2025. DR separately reported experts alleging extensive legal violations by private weight-loss clinics. In Novo's home market the political temperature around this category is higher than the letter of the law suggests.
Who is already there
| Name | Model | Price |
|---|---|---|
| Fit for Livet | Own doctors, nurses and dietitians. Any pharmacy dispenses. The Danish category leader. | 299 DKK / 4 weeks, medicine separate |
| Aposund (Medicals ApS) | In-person weighing at 170+ physical pharmacies with Danmarks Apotekerforening. Names no molecule at all. | 140 DKK / 4 weeks |
| Sikkert Vægttab (Rinnovo Medical) | Clinic prescribes, any pharmacy. 74 brand-named URLs, the most in the Nordics. | 299 DKK / 4 weeks, drug 855 to 4,500 DKK |
| Endolet I/S | Led by an endocrinologist with a PhD on GLP-1 treatment. The only operator offering physical attendance. | 250 DKK / month |
| Embla | Danish digital weight-loss clinic; €10m raised in 2023, UK entry in 2023 | Wegovy 1,283–2,295 DKK/month plus 995 DKK membership |
| Sikkert Vægttab | Video consultations, fixed physician team, four-weekly follow-up, money-back guarantee | 299 DKK/4 weeks plus drug cost |
| Junia, Velform, Diætisthuset, Fit For Livet, mitvaegttab.dk | Membership plus drug-cost telehealth clinics with Danish-licensed physicians | n/a |
Routes in, and walls
What works viable
- Establish a Danish (or EU-passportable) telehealth clinic staffed by Danish-authorised physicians, prescribe via e-recept, and fulfil through an existing independent apotek's mail-order arm.
What does not blocked
- Acquiring or controlling a Danish pharmacy. The bevilling is personal and pharmacist-only.
- Anything resembling branded Rx-drug promotion to consumers, the political climate here is less forgiving than the statute.
How to make it work
The recommended entry path for a non-pharmacist operator running an own brand with a partner pharmacy. Read it against the six axes above, not instead of them.
Run a Danish-authorised clinic, prescribe into e-recept, let any pharmacy dispense, and put no video marketing anywhere except your own website.
You can never own the pharmacy end. Apotekerloven section 15 reserves licences to natural persons holding a pharmaceutical degree, though it does accept equivalent foreign degrees, so this is a structural wall rather than a nationality one. Everything else about Denmark is good: prescribing is the most liberal in the atlas, the market is fully cash-pay, and it is the one Nordic market with a genuinely domestic category leader rather than a pan-European one. But the advertising regime is the hardest in Europe.
- Stand up the clinic with Danish-authorised doctors, nurses and dietitiansFit for Livet does exactly this and is profitable at 8.8m DKK net on 31 staff.
- Prescribe into e-recept and let the patient collect anywhereThere is no captive pharmacy model in Denmark and you do not need one. The leaders link out to the regulator’s own list of approved online retailers.
- Delete video from every channel except your own websiteLov om markedsføring af sundhedsydelser makes marketing a health service in video form unlawful anywhere else, whether or not you name a drug. Meta and YouTube creative is illegal here even with the molecule withheld. This closes the naming-abstention loophole that works in Germany.
- Assume Styrelsen for Patientsikkerhed will inspect youIt ran a named campaign on digital weight-loss providers and has opened roughly 500 cases in three years. Write to your GP as a matter of course; the påbud against Klinik Øregaard turned on zero of about 200 patient courses having information passed to the patient’s own doctor.
- Price against Aposund, not against the digital playersAposund runs in-person weighing at more than 170 pharmacy counters with the pharmacists’ own trade association at 140 DKK per four weeks. You cannot beat that on price or on verification quality.
Aposund. It has taken the one asset a foreign entrant cannot own, the physical pharmacy counter, turned it into a biometric verification layer, and priced below what a pure-digital competitor can sustain.
Low capital, fast. The real cost is giving up video acquisition, which is most of the category’s playbook everywhere else.
What has happened
What we could not establish
Kept visible on purpose. These are the gaps a decision would have to close.
- What did the DR investigation into private weight-loss clinics actually find? The full article was inaccessible.
- Did ENLI issue any formal ruling on the Novo campaign, or was the pause purely voluntary?
- What is the status of the 2024 apotekerloven amendment proposal?
Sources
Every non-obvious claim above links here. Confidence tags are applied strictly.
Read next
Yazen
The only operator in this atlas that never touches the drug, and the only one that runs eight countries out of a single Swedish company under Swedish law.
companyEmbla
One of the earliest European GLP-1-native clinics, built on the Danish clinic-prescribes / pharmacy-dispenses model.
companyFit for Livet
Denmark’s category leader and the most aggressive namer of molecules in the Nordics, already exporting to three other markets.
companyAposund
The one asset a foreign entrant cannot buy: medical weight loss delivered through the physical Danish pharmacy counter, in partnership with the pharmacists’ own trade association.
companySikkert Vægttab
Runs 74 brand-named URLs, more per site than Zava or DoktorABC manage in Germany, plus waiting lists for two medicines it says are not available in Denmark.
company